FDA Approved: BUPHENYL — Supplemental Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for BUPHENYL (sodium phenylbutyrate) from Horizon Therapeutics USA, Inc., expanding its approved labeling for the treatment of u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urea Cycle Disorder

Drugs mentioned

• BUPHENYL (Sodium phenylbutyrate)

Snippet

SUPPL AP for BUPHENYL (SODIUM PHENYLBUTYRATE)